Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
The NCI invites R21 applications (2-year, clinical trial optional) to support early-stage, exploratory population-science research that advances cancer control through surveillance, epidemiology, behavioral science, health care delivery, and related methods. Projects should be high-risk/high-reward with limited preliminary data and aim to develop novel methods, tools, interventions, or models …
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
National Institutes of Health ▸ National Cancer Institute
-
Cancer Prevention Fellowship - Post-doctoral Program
Harvard T.H. Chan School of Public Health
-
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
National Institutes of Health ▸ National Cancer Institute
-
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
National Institutes of Health ▸ National Cancer Institute
-
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers